{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,2]],"date-time":"2026-02-02T22:11:34Z","timestamp":1770070294396,"version":"3.49.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Immunology"],"published-print":{"date-parts":[[2005,11]]},"DOI":"10.1016\/j.it.2005.09.001","type":"journal-article","created":{"date-parts":[[2005,9,16]],"date-time":"2005-09-16T16:40:21Z","timestamp":1126888821000},"page":"580-586","source":"Crossref","is-referenced-by-count":52,"title":["SLE: challenges and candidates in human disease"],"prefix":"10.1016","volume":"26","author":[{"given":"Jennifer A.","family":"Croker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert P.","family":"Kimberly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.it.2005.09.001_bib1","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1002\/1529-0131(199807)41:7<1161::AID-ART4>3.0.CO;2-K","article-title":"Systemic lupus erythematosus in three ethnic groups: I. The effects of HLA class II, C4, and CR1 alleles, socioeconomic factors, and ethnicity at disease onset. LUMINA Study Group. Lupus in minority populations, nature versus nurture","volume":"41","author":"Reveille","year":"1998","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.it.2005.09.001_bib2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1074-7613(01)00201-1","article-title":"Delineating the genetic basis of systemic lupus erythematosus","volume":"15","author":"Wakeland","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/j.it.2005.09.001_bib3","series-title":"Systemic Lupus Erythematosus","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/B9-78-012433-9\/01950-0065","article-title":"Etiopathogenesis of Systemic Lupus Erythematosus","author":"Alarcon-Segovia","year":"2004"},{"key":"10.1016\/j.it.2005.09.001_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2249.2005.02795.x","article-title":"New therapies for systemic lupus erythematosus","volume":"140","author":"Goldblatt","year":"2005","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.it.2005.09.001_bib5","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1002\/art.1780251101","article-title":"The 1982 revised criteria for the classification of systemic lupus erythematosus","volume":"25","author":"Tan","year":"1982","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.it.2005.09.001_bib6","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1002\/art.1780400928","article-title":"Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus","volume":"40","author":"Hochberg","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.it.2005.09.001_bib7","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1002\/art.1780310701","article-title":"Measurement of systemic lupus erythematosus activity in clinical research","volume":"31","author":"Liang","year":"1988","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.it.2005.09.001_bib8","first-page":"927","article-title":"Development and assessment of a computerized index of clinical disease activity in systemic lupus erythematosus. Members of the British Isles Lupus Assessment Group (BILAG)","volume":"69","author":"Symmons","year":"1988","journal-title":"Q. J. Med."},{"key":"10.1016\/j.it.2005.09.001_bib9","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1002\/art.1780350606","article-title":"Derivation of the SLEDAI. A disease activity index for lupus patients. The Committee on Prognosis Studies in SLE","volume":"35","author":"Bombardier","year":"1992","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.it.2005.09.001_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/0961203305lu2064oa","article-title":"Novel therapies in lupus nephritis","volume":"14","author":"Tahir","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.it.2005.09.001_bib11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1053\/sarh.2000.7173","article-title":"The pathogenesis of autoimmunity in New Zealand mice","volume":"29","author":"Borchers","year":"2000","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.it.2005.09.001_bib12","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1084\/jem.20020165","article-title":"Genetic modifiers of systemic lupus erythematosus in Fc\u03b3RIIB\u2212\/\u2212 mice","volume":"195","author":"Bolland","year":"2002","journal-title":"J. Exp. Med."},{"issue":"Suppl 3","key":"10.1016\/j.it.2005.09.001_bib13","doi-asserted-by":"crossref","first-page":"S255","DOI":"10.1186\/ar583","article-title":"Susceptibility genes in the pathogenesis of murine lupus","volume":"4","author":"Nguyen","year":"2002","journal-title":"Arthritis Res."},{"key":"10.1016\/j.it.2005.09.001_bib14","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.semarthrit.2004.07.002","article-title":"Autoantibody explosion in systemic lupus erythematosus: more than 100 different antibodies found in SLE patients","volume":"34","author":"Sherer","year":"2004","journal-title":"Semin. Arthritis Rheum."},{"key":"10.1016\/j.it.2005.09.001_bib15","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S1568-9972(03)00018-1","article-title":"The anti-Sm immune response in autoimmunity and cell biology","volume":"2","author":"Zieve","year":"2003","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.it.2005.09.001_bib16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1084\/jem.20050338","article-title":"Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus","volume":"202","author":"Christensen","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2005.09.001_bib17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1056\/NEJM196803072781004","article-title":"Immunologic factors and clinical activity in systemic lupus erythematosus","volume":"278","author":"Schur","year":"1968","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2005.09.001_bib18","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1056\/NEJMoa021933","article-title":"Development of autoantibodies before the clinical onset of systemic lupus erythematosus","volume":"349","author":"Arbuckle","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.it.2005.09.001_bib19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1191\/0961203305lu2054oa","article-title":"Pathogenic autoantibodies in lupus nephritis","volume":"14","author":"Waldman","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.it.2005.09.001_bib20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1191\/096120399678847704","article-title":"Systemic lupus erythematosus in three ethnic groups: III. A comparison of characteristics early in the natural history of the LUMINA cohort. LUpus in MInority populations: NAture vs nurture","volume":"8","author":"Alarc\u00f3n","year":"1999","journal-title":"Lupus"},{"key":"10.1016\/j.it.2005.09.001_bib21","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1191\/0961203302lu158oa","article-title":"Systemic lupus erythematosus in three ethnic groups: XII. Risk factors for lupus nephritis after diagnosis","volume":"11","author":"Bastian","year":"2002","journal-title":"Lupus"},{"key":"10.1016\/j.it.2005.09.001_bib22","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1191\/0961203303lu440oa","article-title":"Improvement in health-related quality of life in systemic lupus erythematosus patients enrolled in a randomized clinical trial comparing LJP 394 treatment with placebo","volume":"12","author":"Strand","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.it.2005.09.001_bib23","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/art.10558","article-title":"Guidelines for immunologic laboratory testing in the rheumatic diseases: anti-DNA antibody tests","volume":"47","author":"Kavanaugh","year":"2002","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.it.2005.09.001_bib24","first-page":"63","article-title":"Fluctuation of anti-Ro\/SS-A antibody levels in patients with systemic lupus erythematosus and Sjogren's syndrome: a prospective study","volume":"17","author":"Praprotnik","year":"1999","journal-title":"Clin. Exp. Rheumatol."},{"key":"10.1016\/j.it.2005.09.001_bib25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1080\/rhe.31.3.133.139","article-title":"Serial analysis of Ro\/SSA and La\/SSB antibody levels and correlation with clinical disease activity in patients with systemic lupus erythematosus","volume":"31","author":"Hassan","year":"2002","journal-title":"Scand. J. Rheumatol."},{"key":"10.1016\/j.it.2005.09.001_bib26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.clindermatol.2003.12.019","article-title":"Neonatal lupus erythematosus","volume":"22","author":"Boh","year":"2004","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.it.2005.09.001_bib27","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1136\/ard.2004.024943","article-title":"Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus","volume":"64","author":"Marto","year":"2005","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.it.2005.09.001_bib28","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/1529-0131(199907)42:7<1309::AID-ANR1>3.0.CO;2-F","article-title":"International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop","volume":"42","author":"Wilson","year":"1999","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.it.2005.09.001_bib29","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1191\/0961203303lu1015oa","article-title":"Predictive value of autoantibodies for activity of systemic lupus erythematosus","volume":"13","author":"Reveille","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.it.2005.09.001_bib30","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1073\/pnas.0337679100","article-title":"Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus","volume":"100","author":"Baechler","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.it.2005.09.001_bib31","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1084\/jem.20021553","article-title":"Interferon and granulopoiesis signatures in systemic lupus erythematosus blood","volume":"197","author":"Bennett","year":"2003","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2005.09.001_bib32","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1002\/art.21031","article-title":"Activation of the interferon-\u03b1 pathway identifies a subgroup of systemic lupus erythematosus patients with distinct serologic features and active disease","volume":"52","author":"Kirou","year":"2005","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.it.2005.09.001_bib33","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1080\/08916930310001602128","article-title":"Role of natural interferon-\u03b1 producing cells (plasmacytoid dendritic cells) in autoimmunity","volume":"36","author":"Ronnblom","year":"2003","journal-title":"Autoimmunity"},{"key":"10.1016\/j.it.2005.09.001_bib34","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1084\/jem.20031942","article-title":"Toll-like receptor 9-dependent and -independent dendritic cell activation by chromatin-immunoglobulin G complexes","volume":"199","author":"Boule","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.it.2005.09.001_bib35","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s00109-005-0658-0","article-title":"Single-nucleotide polymorphisms in the C-reactive protein (CRP) gene promoter that affect transcription factor binding, alter transcriptional activity, and associate with differences in baseline serum CRP level","volume":"83","author":"Szalai","year":"2005","journal-title":"J. Mol. Med."},{"key":"10.1016\/j.it.2005.09.001_bib36","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1006\/clin.1994.1005","article-title":"Decreased autoantibody levels and enhanced survival of (NZB x NZW) F1 mice treated with C-reactive protein","volume":"70","author":"Du Clos","year":"1994","journal-title":"Clin. Immunol. Immunopathol."},{"key":"10.1016\/j.it.2005.09.001_bib37","first-page":"222","article-title":"Relationship between peripheral blood dendritic cells and cytokines involved in the pathogenesis of systemic lupus erythematosus","volume":"15","author":"Robak","year":"2004","journal-title":"Eur. Cytokine Netw."},{"key":"10.1016\/j.it.2005.09.001_bib38","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1097\/01.bor.0000169360.15701.27","article-title":"Genetics of susceptibility and severity in SLE","volume":"17","author":"Croker","year":"2005","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.it.2005.09.001_bib39","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1038\/35010115","article-title":"TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease","volume":"404","author":"Gross","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.it.2005.09.001_bib40","doi-asserted-by":"crossref","first-page":"6","DOI":"10.4049\/jimmunol.166.1.6","article-title":"Cutting edge: a role for B lymphocyte stimulator in systemic lupus erythematosus","volume":"166","author":"Zhang","year":"2001","journal-title":"J. Immunol."},{"key":"10.1016\/j.it.2005.09.001_bib41","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1002\/art.20430","article-title":"B cell depletion as a novel treatment for systemic lupus erythematosus: a Phase I\/II dose-escalation trial of rituximab","volume":"50","author":"Looney","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.it.2005.09.001_bib42","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1517\/14728222.9.3.431","article-title":"B cells as a therapeutic target in autoimmune diseases","volume":"9","author":"Park","year":"2005","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.it.2005.09.001_bib43","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nri799","article-title":"Marginal-zone B cells","volume":"2","author":"Martin","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.it.2005.09.001_bib44","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.clim.2004.05.001","article-title":"T cells in the pathogenesis of systemic lupus erythematosus","volume":"113","author":"Hoffman","year":"2004","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.it.2005.09.001_bib45","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1191\/0961203305lu2136oa","article-title":"Block and tackle: CTLA4Ig takes on lupus","volume":"14","author":"Davidson","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.it.2005.09.001_bib46","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1038\/ni1184","article-title":"Natural regulatory T cells and self-tolerance","volume":"6","author":"Schwartz","year":"2005","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.it.2005.09.001_bib47","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/art.1780400506","article-title":"The reliability of the Systemic Lupus International Collaborating Clinics\/American College of Rheumatology Damage Index in patients with systemic lupus erythematosus","volume":"40","author":"Gladman","year":"1997","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.it.2005.09.001_bib48","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1002\/art.20578","article-title":"Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXII. Predictors of time to the occurrence of initial damage","volume":"50","author":"Toloza","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.it.2005.09.001_bib49","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1093\/rheumatology\/keg481","article-title":"Systemic lupus erythematosus in three ethnic groups. XX. Damage as a predictor of further damage","volume":"43","author":"Alarcon","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.it.2005.09.001_bib50","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1191\/096120301670679959","article-title":"Early damage as measured by the SLICC\/ACR damage index is a predictor of mortality in systemic lupus erythematosus","volume":"10","author":"Rahman","year":"2001","journal-title":"Lupus"},{"key":"10.1016\/j.it.2005.09.001_bib51","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1093\/rheumatology\/keh238","article-title":"Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus\u2013a 5-yr prospective study","volume":"43","author":"Stoll","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.it.2005.09.001_bib52","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/j.1365-2796.2005.01502.x","article-title":"SLE, atherosclerosis and cardiovascular disease","volume":"257","author":"Frostegard","year":"2005","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.it.2005.09.001_bib53","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/art.11418","article-title":"Comparison of risk factors for vascular disease in the carotid artery and aorta in women with systemic lupus erythematosus","volume":"50","author":"Selzer","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.it.2005.09.001_bib54","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1191\/0961203303lu1016oa","article-title":"New insights into complement: a mediator of injury and marker of disease activity in systemic lupus erythematosus","volume":"13","author":"Manzi","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.it.2005.09.001_bib55","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/01.ATV.0000150415.18759.36","article-title":"Decreased binding of annexin V to endothelial cells: a potential mechanism in atherothrombosis of patients with systemic lupus erythematosus","volume":"25","author":"Cederholm","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1016\/j.it.2005.09.001_bib56","series-title":"Systemic Lupus Erythematosus","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/B9-78-012433-9\/01950-0314","article-title":"Cognitive dysfunction in systemic lupus erythematosus","author":"Denburg","year":"2004"},{"key":"10.1016\/j.it.2005.09.001_bib57","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.immuni.2004.07.011","article-title":"Cognition and immunity; antibody impairs memory","volume":"21","author":"Kowal","year":"2004","journal-title":"Immunity"},{"key":"10.1016\/j.it.2005.09.001_bib58","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/sj.gene.6363966","article-title":"Analysis of gene expression profiles in human systemic lupus erythematosus using oligonucleotide microarray","volume":"4","author":"Han","year":"2003","journal-title":"Genes Immun."},{"key":"10.1016\/j.it.2005.09.001_bib59","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1093\/intimm\/dxh030","article-title":"Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases","volume":"16","author":"Fujimoto","year":"2004","journal-title":"Int. Immunol."},{"key":"10.1016\/j.it.2005.09.001_bib60","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1002\/eji.200323794","article-title":"Fc\u03b3RIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease","volume":"33","author":"Yajima","year":"2003","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.it.2005.09.001_bib61","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1191\/096120398678919831","article-title":"Measurement of damage in 210 Mexican patients with systemic lupus erythematosus: relationship with disease duration","volume":"7","author":"Zonana-Nacach","year":"1998","journal-title":"Lupus"},{"key":"10.1016\/j.it.2005.09.001_bib62","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1191\/0961203304lu2030oa","article-title":"Antiphospholipid antibodies predict early damage in patients with systemic lupus erythematosus","volume":"13","author":"Ruiz-Irastorza","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.it.2005.09.001_bib63","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1093\/rheumatology\/keh384","article-title":"Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort","volume":"43","author":"Mikdashi","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.it.2005.09.001_bib64","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/rheumatology\/keg078","article-title":"Association of damage with autoantibody profile, age, race, sex and disease duration in systemic lupus erythematosus","volume":"42","author":"Yee","year":"2003","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.it.2005.09.001_bib65","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1002\/1529-0131(200112)44:12<2797::AID-ART467>3.0.CO;2-9","article-title":"Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual","volume":"44","author":"Alarcon","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.it.2005.09.001_bib66","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/rheumatology\/keh048","article-title":"Early clinical manifestations, disease activity and damage of systemic lupus erythematosus among two distinct US Hispanic subpopulations","volume":"43","author":"Vila","year":"2004","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.it.2005.09.001_bib67","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1136\/ard.59.10.832","article-title":"Do present damage and health perception in patients with systemic lupus erythematosus predict extent of future damage?: a prospective study","volume":"59","author":"Stoll","year":"2000","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.it.2005.09.001_bib68","first-page":"1513","article-title":"Damage accrual in southern Chinese patients with systemic lupus erythematosus","volume":"30","author":"Mok","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.it.2005.09.001_bib69","first-page":"1884","article-title":"Systemic lupus erythematosus in North American Indians: a population based study","volume":"27","author":"Peschken","year":"2000","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.it.2005.09.001_bib70","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s10067-003-0724-3","article-title":"Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus \u2013 relationship with disease activity and renal involvement","volume":"22","author":"Oelzner","year":"2003","journal-title":"Clin. Rheumatol."},{"key":"10.1016\/j.it.2005.09.001_bib71","first-page":"1761","article-title":"Information on diagnosis and management of systemic lupus erythematosus derived from the routine measurement of 8 nuclear autoantibodies","volume":"30","author":"Ignat","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.it.2005.09.001_bib72","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.1002\/1529-0131(200110)44:10<2350::AID-ART398>3.0.CO;2-A","article-title":"A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus","volume":"44","author":"Ho","year":"2001","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.it.2005.09.001_bib73","doi-asserted-by":"crossref","first-page":"3596","DOI":"10.1002\/art.20561","article-title":"Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus","volume":"50","author":"Manzi","year":"2004","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.it.2005.09.001_bib74","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1191\/0961203304lu1053oa","article-title":"Reduced erythrocyte complement receptor type 1 in systemic lupus erythematosus is related to a disease activity index and not to the presence or severity of renal disease","volume":"13","author":"de Carvalho Lins","year":"2004","journal-title":"Lupus"},{"key":"10.1016\/j.it.2005.09.001_bib75","first-page":"454","article-title":"Studies of serum C-reactive protein in systemic lupus erythematosus","volume":"32","author":"Williams","year":"2005","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.it.2005.09.001_bib76","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/art.10949","article-title":"Correlation between circulating CD27high plasma cells and disease activity in patients with systemic lupus erythematosus","volume":"48","author":"Jacobi","year":"2003","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.it.2005.09.001_bib77","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1365-2249.2004.02607.x","article-title":"Interleukin (IL)-10, IL-1ra and IL-12 profiles in active and quiescent systemic lupus erythematosus: could longitudinal studies reveal patient subgroups of differing pathology?","volume":"138","author":"Capper","year":"2004","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.it.2005.09.001_bib78","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3109\/08916939908994055","article-title":"Reduced in vitro production of interferon-\u03b3, interleukin-4 and interleukin-12 and increased production of interleukin-6, interleukin-10 and tumour necrosis factor-\u03b1 in systemic lupus erythematosus. Weak correlations of cytokine production with disease activity","volume":"31","author":"Jones","year":"1999","journal-title":"Autoimmunity"},{"key":"10.1016\/j.it.2005.09.001_bib79","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1191\/0961203303lu456rr","article-title":"Antineutrophil cytoplasmic autoantibodies in systemic lupus erythematosus","volume":"12","author":"Sen","year":"2003","journal-title":"Lupus"},{"key":"10.1016\/j.it.2005.09.001_bib80","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1681\/ASN.2004080658","article-title":"Urine chemokines as biomarkers of human systemic lupus erythematosus activity","volume":"16","author":"Rovin","year":"2005","journal-title":"J. Am. Soc. Nephrol."}],"container-title":["Trends in Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149060500236X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S147149060500236X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,24]],"date-time":"2019-03-24T02:18:16Z","timestamp":1553393896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S147149060500236X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11]]},"references-count":80,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2005,11]]}},"alternative-id":["S147149060500236X"],"URL":"https:\/\/doi.org\/10.1016\/j.it.2005.09.001","relation":{},"ISSN":["1471-4906"],"issn-type":[{"value":"1471-4906","type":"print"}],"subject":[],"published":{"date-parts":[[2005,11]]}}}